Bellvitge University Hospital / Hospital Universitari de Bellvitge
Hospital
Location:
L'Hospitalet de Llobregat,
Spain (ES)
ISNI: 0000000088360780
ROR: https://ror.org/00epner96
Statin use does not impair muscle health in older adults: findings from the SCOPE study (2026)
Fazel SD, Tap L, Fabbietti P, Corsonello A, Kob R, Sieber CC, Roller-Wirnsberger R, et al.
Journal article
Endostatin, chronic kidney disease (CKD) and anemia among older people: a secondary analysis of the screening for CKD among older people across Europe (SCOPE) study (2026)
Corsonello A, Soraci L, Ärnlöv J, Carlsson AC, Feldreich TR, Larsson A, Roller-Wirnsberger R, et al.
Journal article
World Federation of Societies of Biological Psychiatry (WFSBP) consensus statement on candidate biomarkers for anorexia nervosa (2026)
Himmerich H, Keeler JL, King JA, Ehrlich S, Kaufmann LK, Bulik CM, Cohen-Woods S, et al.
Journal article, Review article
Cholangiocarcinoma 2026: status quo, unmet needs and priorities (2026)
Banales JM, Rodrigues PM, Affò S, Andersen JB, Aspichueta P, Boulter L, Bridgewater J, et al.
Journal article, Review article
Effects of Semaglutide on Body Composition and Glomerular Filtration Rate: A Prespecified Analysis of the SMART Trial (2026)
Heerspink HJ, Soler M, Beernink JM, Jongs N, Cigarran S, Cruzado JM, Puchades MJ, et al.
Journal article
Characteristics of fall recurrence among persistent, quasi-persistent, and transient fallers: a 3-year analysis from the SCOPE study (2026)
Melzer I, Freiberger E, Britting S, Lattanzio F, Corsonello A, Melzer Y, Artzi-Medvedick R, et al.
Journal article
Treatment discontinuation rates due to lack of efficacy through 1 year of maintenance treatment with vedolizumab or subcutaneous infliximab in patients with inflammatory bowel disease: a systematic literature review and meta-analysis (2025)
Ferrante M, Peyrin-Biroulet L, Arkkila P, Armuzzi A, Colombel JF, Danese S, Faggiani R, et al.
Journal article
Rationale and design of the Renal Lifecycle trial assessing the effect of dapagliflozin on cardiorenal outcomes in severe chronic kidney disease (2025)
Bakker WM, Heerspink HJ, Berger SP, Wanner C, Badve SV, Arnott C, Abrahams AC, et al.
Journal article
Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial (2024)
Harbeck N, Ciruelos E, Jerusalem G, Müller V, Niikura N, Viale G, Bartsch R, et al.
Journal article
Publisher Correction: Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial(Nature Medicine, 10.1038/s41591-024-03261-7) (2024)
Harbeck N, Ciruelos E, Jerusalem G, Müller V, Niikura N, Viale G, Bartsch R, et al.
Journal article, Erratum